10 20 30 40 50 60 70 80 1YSI - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER APOPTOSIS 08-FEB-05 1YSI
TITLE SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN TITLE 2 COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND
COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-X; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BCL-2-LIKE 1 PROTEIN; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2L1, BCL2L, BCLX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET30B
KEYWDS COMPLEX, APOPTOSIS
EXPDTA SOLUTION NMR
AUTHOR T.OLTERSDORF,S.W.ELMORE,A.R.SHOEMAKER,R.C.ARMSTRONG, AUTHOR 2 D.J.AUGERI,B.A.BELLI,M.BRUNCKO,T.L.DECKWERTH,J.DINGES, AUTHOR 3 P.J.HAJDUK,M.K.JOSEPH,S.KITADA,S.J.KORSMEYER,A.R.KUNZER, AUTHOR 4 A.LETAI,C.LI,M.J.MITTEN,D.G.NETTESHEIM,S.NG,P.M.NIMMER, AUTHOR 5 J.M.O'CONNOR,A.OLEKSIJEW,A.M.PETROS,J.C.REED,W.SHEN, AUTHOR 6 S.K.TAHIR,C.B.THOMPSON,K.J.TOMASELLI,B.WANG,M.D.WENDT, AUTHOR 7 H.ZHANG,S.W.FESIK,S.H.ROSENBERG
REVDAT 3 24-FEB-09 1YSI 1 VERSN REVDAT 2 23-OCT-07 1YSI 1 REMARK REVDAT 1 07-JUN-05 1YSI 0
JRNL AUTH T.OLTERSDORF,S.W.ELMORE,A.R.SHOEMAKER, JRNL AUTH 2 R.C.ARMSTRONG,D.J.AUGERI,B.A.BELLI,M.BRUNCKO, JRNL AUTH 3 T.L.DECKWERTH,J.DINGES,P.J.HAJDUK,M.K.JOSEPH, JRNL AUTH 4 S.KITADA,S.J.KORSMEYER,A.R.KUNZER,A.LETAI,C.LI, JRNL AUTH 5 M.J.MITTEN,D.G.NETTESHEIM,S.NG,P.M.NIMMER, JRNL AUTH 6 J.M.O'CONNOR,A.OLEKSIJEW,A.M.PETROS,J.C.REED, JRNL AUTH 7 W.SHEN,S.K.TAHIR,C.B.THOMPSON,K.J.TOMASELLI,B.WANG, JRNL AUTH 8 M.D.WENDT,H.ZHANG,S.W.FESIK,S.H.ROSENBERG JRNL TITL AN INHIBITOR OF BCL-2 FAMILY PROTEINS INDUCES JRNL TITL 2 REGRESSION OF SOLID TUMOURS JRNL REF NATURE V. 435 677 2005 JRNL REFN ISSN 0028-0836 JRNL PMID 15902208 JRNL DOI 10.1038/NATURE03579
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1YSI COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAR-05. REMARK 100 THE RCSB ID CODE IS RCSB031880.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 50 MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1MM BCL-XL U-15N,13C 50MM REMARK 210 SODIUM PHOSPHATE, 5 MM REMARK 210 DEUTERATED DITHIOTHREITOL, REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY, 3D_ REMARK 210 13C-EDITED_12C-FILTERED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 3 55.83 34.65 REMARK 500 GLN A 7 33.99 -164.78 REMARK 500 ASN A 9 -52.94 -122.23 REMARK 500 SER A 27 -158.15 66.24 REMARK 500 TRP A 28 -45.25 -150.55 REMARK 500 PHE A 31 -72.29 -55.81 REMARK 500 ASP A 33 -124.27 62.74 REMARK 500 VAL A 34 140.82 79.54 REMARK 500 ASN A 37 -79.24 -54.36 REMARK 500 ARG A 38 -71.15 174.13 REMARK 500 THR A 39 61.85 65.16 REMARK 500 GLU A 43 -84.79 61.03 REMARK 500 THR A 45 -43.06 -165.08 REMARK 500 GLU A 46 39.75 32.78 REMARK 500 GLU A 102 48.61 -92.42 REMARK 500 LEU A 103 -57.66 -150.85 REMARK 500 TYR A 105 76.55 -102.40 REMARK 500 ALA A 108 -70.82 -105.86 REMARK 500 ALA A 123 -77.79 179.52 REMARK 500 LYS A 161 -76.41 -78.20 REMARK 500 GLU A 162 37.76 -178.06 REMARK 500 ASP A 180 13.46 -141.44 REMARK 500 LEU A 182 -36.74 -177.62 REMARK 500 ASN A 202 54.86 -142.22 REMARK 500 ARG A 208 -81.35 64.29 REMARK 500 LYS A 209 -97.96 -58.83 REMARK 500 GLN A 211 -89.88 -52.58 REMARK 500 GLU A 212 75.69 52.84 REMARK 500 ARG A 213 -69.03 69.52 REMARK 500 LEU A 214 32.81 -165.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 10 0.29 SIDE_CHAIN REMARK 500 ARG A 38 0.32 SIDE_CHAIN REMARK 500 ARG A 95 0.27 SIDE_CHAIN REMARK 500 ARG A 104 0.30 SIDE_CHAIN REMARK 500 ARG A 106 0.27 SIDE_CHAIN REMARK 500 ARG A 107 0.28 SIDE_CHAIN REMARK 500 ARG A 136 0.28 SIDE_CHAIN REMARK 500 ARG A 143 0.20 SIDE_CHAIN REMARK 500 ARG A 169 0.31 SIDE_CHAIN REMARK 500 ARG A 208 0.31 SIDE_CHAIN REMARK 500 ARG A 213 0.32 SIDE_CHAIN REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE N3B A 1000
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LXL RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF SAME PROTEIN, UNCOMPLEXED REMARK 900 RELATED ID: 1MAZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SAME PROTEIN, UNCOMPLEXED REMARK 900 RELATED ID: 1BXL RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF SAME PROTEIN COMPLEXED WITH BAK REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1G5J RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF SAME PROTEIN COMPLEXED WITH BAD REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1YSG RELATED DB: PDB REMARK 900 RELATED ID: 1YSX RELATED DB: PDB REMARK 900 RELATED ID: 1YSN RELATED DB: PDB REMARK 900 RELATED ID: 1YSW RELATED DB: PDB
REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 49-88 (SEQUENCE DATABASE RESIDUES 45-84) REMARK 999 ARE NOT PRESENT DUE TO A LOOP DELETION.
DBREF 1YSI A 5 48 UNP Q07817 BCLX_HUMAN 1 44 DBREF 1YSI A 89 213 UNP Q07817 BCLX_HUMAN 85 209
SEQADV 1YSI MET A 1 UNP Q07817 EXPRESSION TAG SEQADV 1YSI SER A 2 UNP Q07817 EXPRESSION TAG SEQADV 1YSI MET A 3 UNP Q07817 EXPRESSION TAG SEQADV 1YSI ALA A 4 UNP Q07817 EXPRESSION TAG SEQADV 1YSI LEU A 214 UNP Q07817 EXPRESSION TAG SEQADV 1YSI GLU A 215 UNP Q07817 EXPRESSION TAG SEQADV 1YSI HIS A 216 UNP Q07817 EXPRESSION TAG SEQADV 1YSI HIS A 217 UNP Q07817 EXPRESSION TAG SEQADV 1YSI HIS A 218 UNP Q07817 EXPRESSION TAG SEQADV 1YSI HIS A 219 UNP Q07817 EXPRESSION TAG SEQADV 1YSI HIS A 220 UNP Q07817 EXPRESSION TAG SEQADV 1YSI HIS A 181 UNP Q07817 EXPRESSION TAG
SEQRES 1 A 181 MET SER MET ALA MET SER GLN SER ASN ARG GLU LEU VAL SEQRES 2 A 181 VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY TYR SEQRES 3 A 181 SER TRP SER GLN PHE SER ASP VAL GLU GLU ASN ARG THR SEQRES 4 A 181 GLU ALA PRO GLU GLY THR GLU SER GLU ALA VAL LYS GLN SEQRES 5 A 181 ALA LEU ARG GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR SEQRES 6 A 181 ARG ARG ALA PHE SER ASP LEU THR SER GLN LEU HIS ILE SEQRES 7 A 181 THR PRO GLY THR ALA TYR GLN SER PHE GLU GLN VAL VAL SEQRES 8 A 181 ASN GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE SEQRES 9 A 181 VAL ALA PHE PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SEQRES 10 A 181 SER VAL ASP LYS GLU MET GLN VAL LEU VAL SER ARG ILE SEQRES 11 A 181 ALA ALA TRP MET ALA THR TYR LEU ASN ASP HIS LEU GLU SEQRES 12 A 181 PRO TRP ILE GLN GLU ASN GLY GLY TRP ASP THR PHE VAL SEQRES 13 A 181 GLU LEU TYR GLY ASN ASN ALA ALA ALA GLU SER ARG LYS SEQRES 14 A 181 GLY GLN GLU ARG LEU GLU HIS HIS HIS HIS HIS HIS
HET N3B A1000 60
HETNAM N3B N-[(4'-FLUORO-1,1'-BIPHENYL-4-YL)CARBONYL]-3-NITRO-4- HETNAM 2 N3B {[2-(PHENYLSULFANYL)ETHYL]AMINO}BENZENESULFONAMIDE
FORMUL 2 N3B C27 H22 F N3 O5 S2
HELIX 1 1 ASN A 9 GLY A 25 1 17 HELIX 2 2 ALA A 89 TYR A 105 1 17 HELIX 3 3 PHE A 109 GLN A 115 1 7 HELIX 4 4 ALA A 123 PHE A 135 1 13 HELIX 5 5 ASN A 140 GLU A 162 1 23 HELIX 6 6 LEU A 166 ASP A 180 1 15 HELIX 7 7 LEU A 182 GLY A 190 1 9 HELIX 8 8 GLY A 191 LEU A 198 1 8
SITE 1 AC1 10 PHE A 101 TYR A 105 ALA A 108 PHE A 109 SITE 2 AC1 10 LEU A 134 ASN A 140 GLY A 142 ARG A 143 SITE 3 AC1 10 VAL A 145 TYR A 199
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000